News About: Pharm. Industry
Ursa showing brisk monthly sales
Daewoong Pharm said recently that Ursa (ursodeoxycholic acid; UDCA) capsule, which has been locally recognized as one of the most popular liver protectives for the past 40 years, has witnessed bigger monthly sales of ...
Europeans community to censure MOHW for drug pricing policies.
European Chamber of Commerce of Korea took a press interview at Yeongbin hall of Shilla hotel at 10 a.m. on March 3 under the title of "2004 trade barrier report", pointing out that the Korean government gave special ...
Binex filed IND for a new colon cancer drug.
Binex (President: Lee Baek-cheon) announced that an investigational new drug application (IND) for DC-Vac/IR, a new colon cancer injectable drug, was submitted to KFDA on March 2.
DE-Vac/IR is a new immunological ...
Choong-wae Pharm inks tie-up with MarukoChoong-wae Pharm said on March 2 that it signed a joint partnership with Japan's Maruko Seiyaku Co, one of Japan's leading pharmaceutical makers, to license out its newly develo...
|
Kwangdong Pharm gains foothold in vitamin drink market
With less than a three-year-old Vita-500 drink preparation after launching, Kwangdong Pharm is now moving to accelerate its bid to grasp an initiative in the domestic nutritional drink and tonic markets by making heav...
Chong Kun Dang launches Camtobell injection, camptothecin analogue topoisomerase I inhibitorChong Kun Dang Pharmaceutical Co. said it launched Korea's 8th new drug Camtobell injection for the treatment of ovarian cancer (second-line therapy) and small-cell lung cancer ...
|
Three local firms' shares emerging as higher growth potential this year
With the prevailing prediction that Korea's gross domestic product in 2004 will reach at a 4.8 percent mark while drug's shipment index and output will hover at 8.1 percent and 4.9 percent, respectively, Shinheung Sec...
Government OKs local operation of Institut Pasteur Korea
The Ministry of Science and Technology said it approved the establishment of Institut Pasteur Korea under the provisions of Civil Law on February 26, with an address having 39-1 Hawoelgok-dong, Sungbuk-gu, Seoul.
...
Pacific Pharm. agreed with 11% dividend in stockholder's meeting.
Pacific Pharm. Co. (President Lee Woo-young) had the 22th general shareholder's meeting at 10th fl. of Pacific building on Feb. 27 and decided cash dividends at 11% for common stocks and 12% for preferred stocks.
...
Domestic antihyperlipidemic market heats up
With more than 60 items flooding in the local antihyperlipidemic market, a number of domestic pharmaceutical markers listed in the top 10 ranks are taking up a larger proportion of market share even in the fac...
